Eventide Asset Management – SUTRO BIOPHARMA INC

Eventide Asset Management ownership history of SUTRO BIOPHARMA INC
QuarterValueSharesWeighting
Q1 2021$53,963
4.8%
2,370,9750.0%0.80%
1.4%
Q4 2020$51,474
157.9%
2,370,975
19.4%
0.79%
101.8%
Q3 2020$19,959
29.5%
1,985,9750.0%0.39%
16.7%
Q2 2020$15,411
17.5%
1,985,975
54.4%
0.34%
-21.2%
Q1 2020$13,117
-4.2%
1,285,975
3.3%
0.42%
10.1%
Q4 2019$13,694
187.0%
1,244,895
137.1%
0.39%
144.3%
Q3 2019$4,772
-65.3%
525,000
-57.8%
0.16%
-62.2%
Q2 2019$13,758
-0.1%
1,244,8950.0%0.42%
-11.8%
Q1 2019$13,770
26.3%
1,244,8950.0%0.47%
-1.9%
Q4 2018$10,904
-39.9%
1,244,8950.0%0.48%
-27.5%
Q3 2018$18,1341,244,8950.67%